ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$JANX:NASDAQ · Janux Therapeutics Inc - US

Janux — masked T-cell engager oncology biotech

Sector: health

Conviction from: NASDAQCitrini

52-week range: 10.7335.34

2 tracked filer(s) hold this · 0 opened, 0 added, 2 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s). Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61Trimmed -17%23,307$402,7450.0%
Steve Cohen / Point7275Trimmed -21%1,579,984$27,302,1240.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.